Table 1.

Poly(I:C) stimulation leads to phenotype changes in PMCs



% PMCs

MFI


pIC

pIC
I-A/E   16.6 ± 3.8   92.1 ± 2.2*  944 ± 174   2594 ± 832 
CD80   30.1 ± 7.9   92.7 ± 2.0*  205 ± 14   1366 ± 208* 
CD28   3.3 ± 1.3   36.3 ± 9.7  174 ± 83   89 ± 60  
CD21/35   15.8 ± 3.4   76.9 ± 7.1*  56 ± 4   195 ± 32* 
FcγRII/III     
   High   80.1 ± 3.5   92.3 ± 2.2  453 ± 15   1391 ± 122* 
   Intermediate
 
18.1 ± 3.0
 
7.5 ± 2.2
 
150 ± 7
 
115 ± 6
 


% PMCs

MFI


pIC

pIC
I-A/E   16.6 ± 3.8   92.1 ± 2.2*  944 ± 174   2594 ± 832 
CD80   30.1 ± 7.9   92.7 ± 2.0*  205 ± 14   1366 ± 208* 
CD28   3.3 ± 1.3   36.3 ± 9.7  174 ± 83   89 ± 60  
CD21/35   15.8 ± 3.4   76.9 ± 7.1*  56 ± 4   195 ± 32* 
FcγRII/III     
   High   80.1 ± 3.5   92.3 ± 2.2  453 ± 15   1391 ± 122* 
   Intermediate
 
18.1 ± 3.0
 
7.5 ± 2.2
 
150 ± 7
 
115 ± 6
 

Peritoneal MCs were gated for expression of c-Kit and FcϵRI or S/T2 and determined as 100%. Expression of MHC class II molecules, costimulatory molecules, and complement receptors were analyzed. Peritoneal MCs from 4 to 10 mice each were analyzed.

indicates before stimulation

*

P < .001

P < .05

or Create an Account

Close Modal
Close Modal